Difference between revisions of "Team:Pasteur Paris/Week 10"
(One intermediate revision by one other user not shown) | |||
Line 9: | Line 9: | ||
background-color:#FFFFFF; | background-color:#FFFFFF; | ||
border-right: none; | border-right: none; | ||
− | border-left: none | + | border-left: none; |
padding-left: 10px; | padding-left: 10px; | ||
padding-right: 10px; | padding-right: 10px; | ||
+ | line-height: 10px; | ||
} | } | ||
Line 20: | Line 21: | ||
.week h1 { | .week h1 { | ||
font-family: "Avenir Next","Trebuchet MS", Helvetica, sans-serif; | font-family: "Avenir Next","Trebuchet MS", Helvetica, sans-serif; | ||
− | font-size: 0. | + | font-size: 0.8em; |
color:#9E9E9E; | color:#9E9E9E; | ||
font-weight: 500; | font-weight: 500; | ||
+ | line-height: 10px; | ||
text-shadow: 1px 1px 1px #B2B2B2; | text-shadow: 1px 1px 1px #B2B2B2; | ||
border: none; | border: none; | ||
Line 43: | Line 45: | ||
padding-top: 50px; | padding-top: 50px; | ||
} | } | ||
− | |||
</style> | </style> | ||
Line 114: | Line 115: | ||
<li style="text-align:left">M9</li> | <li style="text-align:left">M9</li> | ||
<li style="text-align:left">M9 + TPA (1.2 mM)</li> | <li style="text-align:left">M9 + TPA (1.2 mM)</li> | ||
− | <li style="text-align:left">M9 + TPA (6 mM)</li> | + | <li style="text-align:left">M9 + TPA (6.0 mM)</li> |
− | <li style="text-align:left">M9 + TPA (12 mM)</li> | + | <li style="text-align:left">M9 + TPA (12.0 mM)</li> |
<li style="text-align:left">M9 + sucrose (1.2 mM)</li> | <li style="text-align:left">M9 + sucrose (1.2 mM)</li> | ||
− | <li style="text-align:left">M9 + sucrose (6 mM)</li> | + | <li style="text-align:left">M9 + sucrose (6.0 mM)</li> |
− | <li style="text-align:left">M9 + sucrose (12 mM)</li> | + | <li style="text-align:left">M9 + sucrose (12.0 mM)</li> |
− | <li style="text-align:left">M9 + sucrose + TPA (6 mM)</li> | + | <li style="text-align:left">M9 + sucrose + TPA (6.0 mM)</li> |
<li style="text-align:left">M9 + sucrose + TPA (1.2 mM)</li> | <li style="text-align:left">M9 + sucrose + TPA (1.2 mM)</li> | ||
Media 11 to 15 are made in both solid and liquid form: | Media 11 to 15 are made in both solid and liquid form: | ||
<li style="text-align:left">LB Broth</li> | <li style="text-align:left">LB Broth</li> | ||
<li style="text-align:left">LB + TPA (1.2 mM)</li> | <li style="text-align:left">LB + TPA (1.2 mM)</li> | ||
− | <li style="text-align:left">LB + TPA (6 mM)</li> | + | <li style="text-align:left">LB + TPA (6.0 mM)</li> |
− | <li style="text-align:left">LB + TPA (12 mM)</li> | + | <li style="text-align:left">LB + TPA (12.0 mM)</li> |
− | <li style="text-align:left">LB + TPA (20 mM)</li> | + | <li style="text-align:left">LB + TPA (20.0 mM)</li> |
</ol> | </ol> | ||
</li> | </li> | ||
</br> | </br> | ||
− | <li style="text-align:left">Growth curve of BAP 1 (E. coli, | + | <li style="text-align:left">Growth curve of BAP 1 (E. coli, kindly provided by Blaine Pfeifer, U. Buffalo)in media 11 to 14 in order to assess TPA toxicity.</li></br> |
<li style="text-align:left">Plating of BAP 1 bacteria on all solid media to assess TPA toxicity and the ability of TPA to be used as a carbon source.</br></br> | <li style="text-align:left">Plating of BAP 1 bacteria on all solid media to assess TPA toxicity and the ability of TPA to be used as a carbon source.</br></br> | ||
</ol> | </ol> |
Latest revision as of 02:15, 19 September 2015
Week 1Week 2Week 3Week 4Week 5Week 6Week 7Week 8Week 9Week 10Week 11Week 12Week 13Week 14Week 15 |
Week 10 Toxicity and solubility of TPA (Terephthalic acid)
Enzymatic Assay of NB-Esterase
![]() Figure 8: Gel for verification of the ligation of BBa_K808030 and pDG011 plasmid. There is no band for the ligation sample. Gibson Assembly
|